Stewart James Baker

Title: Stewart James Baker: Innovator in Pharmaceutical Compounds

Introduction

Stewart James Baker is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work primarily focuses on compounds that have the potential to treat various diseases associated with abnormal cell growth and function.

Latest Patents

Baker's latest patents include innovative pharmaceutical compounds such as fused pyrimidines and thienopyrimidines. The fused pyrimidines are described as having activity as inhibitors of PI3K, which may be used to treat diseases and disorders related to cancer, immune disorders, cardiovascular disease, viral infections, inflammation, metabolism/endocrine disorders, and neurological disorders. Additionally, processes for synthesizing these compounds are also detailed in his patents. The thienopyrimidines similarly exhibit activity as inhibitors of PI3K, particularly the p110 delta subtype, and are aimed at treating similar health issues.

Career Highlights

Throughout his career, Stewart James Baker has worked with prominent companies in the pharmaceutical industry, including F. Hoffmann-La Roche AG and Piramed Limited. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Baker has collaborated with notable professionals in his field, including Stephen Joseph Shuttleworth and Timothy Colin Hancox. These collaborations have likely enhanced the quality and impact of his inventions.

Conclusion

Stewart James Baker is a distinguished inventor whose work in pharmaceutical compounds has the potential to address critical health challenges. His contributions to the field are marked by a commitment to innovation and collaboration.